The latest breeding technology
With an investment of 10% of the yearly turnover from Group Grimaud in Genetics’ R&D and taking part in the GENETECH technology platform (www.genetechbygrimaud.com), Blue Genetics benefits from a team of 35 scientist & researchers who developed the latest innovations and advances within the group, as genome technology, big databases (8.5 TB) and accurate phenotyping.
Such international dimension and innovative R&D aim to make products evolve on the characteristics of major economic interest as growth and resistance, naturally, taking into account our customers local production environment to combine performance, robustness and adaptation to their future expectations.
The development of our growth line is done under a two-step process, where we make a distinction between early growth and late growth and develop both.
Thanks to this approach the growth performance has already more than doubled over the last 10 generations. At the same time we also monitor parameters like spawning performance in order to provide the best possible solution to the industry.
The resistant line has been developed over many generation through direct disease challenges. Only 1% of the best performing surviving animals are used as parents for the next generation.
Using this strong selective pressure the survival rate when challenged with WSSV has been increased from 35% to 75% in our latest generation.